Clinical Studies

GBM-Vax (ongoing)

Randomized phase-II study concerning the treatment of GBM with IL-12 producing DCs as an add-on to standard therapy

Partners: Wagner-Jauregg Linz, Medical University Wien, Medical University Graz, Medical University Innsbruck, Krankenanstalt Rudolfstiftung Wien, Kaiser Franz-Josef Spital Wien, Donauspital Wien, Landeskrankenhaus Feldkirch, Salzburger Landesklinikum, CESAR

DECAVAREC (completed)

Randomized phase II study, cancelled due to lack of participants

Partners: Diverse urological departments in Austria and the Czech Republic